Cargando…
Staphylococcal SSL5 Binding to Human Leukemia Cells Inhibits Cell Adhesion to Endothelial Cells and Platelets
Bacterial proteins provide promising tools for novel anticancer therapies. Staphylococcal superantigen-like 5 (SSL5) was recently described to bind P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes and to inhibit neutrophil rolling on a P-selectin surface. As leukocytes and tumor cells share m...
Autores principales: | Walenkamp, Annemiek M. E., Bestebroer, Jovanka, Boer, Ingrid G. J., Kruizinga, Roeline, Verheul, Henk M., van Strijp, Jos A. G., de Haas, Carla J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619234/ https://www.ncbi.nlm.nih.gov/pubmed/20208131 http://dx.doi.org/10.3233/CLO-2009-0486 |
Ejemplares similares
-
Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 & SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition
por: Koymans, Kirsten J., et al.
Publicado: (2016) -
Molecular basis determining species specificity for TLR2 inhibition by staphylococcal superantigen-like protein 3 (SSL3)
por: Koymans, Kirsten J., et al.
Publicado: (2018) -
Neutrophil-Mediated Phagocytosis of Staphylococcus aureus
por: van Kessel, Kok P. M., et al.
Publicado: (2014) -
SSL and TLS
por: Oppliger, Rolf
Publicado: (2016) -
Studying Staphylococcal Leukocidins: A Challenging Endeavor
por: Tromp, Angelino T., et al.
Publicado: (2020)